Thromboembolism
📧 Sign up to get email alerts when something new happens for Thromboembolism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Safety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in Thromboembolism [Phase 1]
A Phase 1 trial evaluating safety, pharmacokinetics, biodistribution, and diagnostic performance of the PET tracer [18F]GP1 for detecting th…
-
CLINICAL_TRIALS trial_result · 2018-01-25Clinical Trial Update: Tecarfarin Anti-Coagulation Trial (TACT) [Phase 3]
Phase 3 clinical trial update for Tecarfarin in anticoagulation (TACT) investigating prevention of thromboembolism and thrombosis. Status is…
-
CLINICAL_TRIALS trial_result · 2017-10-11Clinical Trial Update: Hip Fracture Study of GSK576428 (Fondaparinux Sodium) [Phase 3]
Phase 3 trial update for fondaparinux sodium (GSK576428) in a hip fracture study; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2017-06-28Clinical Trial Update: Comparison of Accidents and Their Circumstances With Oral Anticoagulants
This completed clinical trial evaluates accidents and the circumstances surrounding them in patients taking oral anticoagulants. It was cond…
-
CLINICAL_TRIALS trial_result · 2016-09-15Clinical Trial Update: Michelangelo - Oasis 5 [Phase 3]
Phase 3 clinical trial for thromboembolism conducted by GlaxoSmithKline has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-08-22Clinical Trial Update: Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy
Clinical trial update on biomarkers related to thrombosis in patients with newly diagnosed multiple myeloma receiving chemotherapy. The stud…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome [NA]
Dose-adjusting enoxaparin thromboprophylaxis based on anti-factor Xa levels during pregnancy may improve outcomes in women at risk for fetal…
-
CLINICAL_TRIALS trial_result · 2015-09-25Clinical Trial Update: Pradaxa (Dabigatran Etexilate) 150 mg/q.d. in Patients With Moderate Renal Impairment After Hip or Knee Replacement Surgery
A completed clinical trial assessing dabigatran etexilate 150 mg once daily for prevention of thromboembolism after hip or knee replacement …
-
CLINICAL_TRIALS research · 2015-08-07Clinical Trial Update: Epidemiology of Venous Thromboembolism
This document provides an update on the epidemiology of venous thromboembolism from a completed Brigham and Women's Hospital–sponsored trial…
-
CLINICAL_TRIALS trial_result · 2015-05-20Clinical Trial Update: Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation [Phase 3]
Phase 3 trial update evaluating warfarin (Coumadin) for preventing thromboembolism in atrial fibrillation patients undergoing catheter ablat…
-
CLINICAL_TRIALS trial_result · 2015-03-13Clinical Trial Update: A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-valvular Atrial Fibrillation [Phase 2]
A Phase 2 study assessing the safety of a potential new drug versus warfarin for non-valvular atrial fibrillation, completed with results po…
-
CLINICAL_TRIALS trial_result · 2015-02-09Clinical Trial Update: A Phase 2b Study of DU-176b, Prevention of Venous Thromboembolism in Patients After Total Hip Arthroplasty [Phase 2]
Phase 2b study of DU-176b for prevention of venous thromboembolism after total hip arthroplasty has completed with results posted.
-
CLINICAL_TRIALS research · 2014-12-10Clinical Trial Update: Investigation on Appropriate Duration of Dabigatran Use After Catheter Ablation for Paroxysmal Atrial Fibrillation in Patients With Low Thromboembolic Risk [Phase 3]
A Phase 3 clinical trial is investigating the optimal duration of dabigatran after catheter ablation in patients with paroxysmal atrial fibr…
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Anticoagulant After Implantation of Biological Aortic Valve Comparing With Aspirin [Phase 4]
Phase 4 clinical trial comparing an anticoagulant with aspirin after biological aortic valve implantation has completed.
-
CLINICAL_TRIALS trial_result · 2014-07-11Clinical Trial Update: Follow on Study From RE-ALIGN [Phase 2]
A Phase 2 follow-on study from RE-ALIGN evaluating dabigatran in patients with thromboembolism and prosthetic heart valves was terminated; r…
-
CLINICAL_TRIALS trial_result · 2014-07-04Clinical Trial Update: Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology [NA]
Clinical trial update on aspirin and compression devices for venous thromboembolism prophylaxis in orthopaedic oncology completed, with resu…
-
CLINICAL_TRIALS trial_result · 2013-09-30Clinical Trial Update: Evaluation of Contrast Medium Enhanced Post-mortem CT in Virtual Autopsy
This completed trial evaluated contrast-enhanced post-mortem CT imaging for virtual autopsy to assess thromboembolism and vascular condition…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: SALTO - Epidemiological Study on Compliance and Treatment Satisfaction
A completed epidemiological study sponsored by Bayer evaluating patient compliance and treatment satisfaction in thromboembolism.
-
CLINICAL_TRIALS trial_result · 2013-08-07Clinical Trial Update: Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters [NA]
This clinical trial update notes the completion of a study evaluating warfarin to prevent thromboembolism in cancer patients with central ve…
-
CLINICAL_TRIALS trial_result · 2013-02-21Clinical Trial Update: HTRS TE Registry (ThromboEmbolism Registry)
Update on the HTRS Thromboembolism Registry indicating the registry has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-16Clinical Trial Update: Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer [Phase 2]
A Phase 2 trial evaluated combining chemotherapy with warfarin for patients with prostate cancer and thromboembolism; the study status is co…
-
EMA withdrawal · 2012-07-27EMA Withdrawn: Refludan (lepirudin) — Celgene Europe Ltd.
EMA withdrew Refludan (lepirudin) from the market in 2012, with thromboembolism and thrombocytopenia as therapeutic areas.
-
CLINICAL_TRIALS research · 2011-03-21Clinical Trial Update: Subclinical Atherosclerosis Using Dual-source CT Coronary Angiography in Chinese Adults With Different Glycaemic Status
Clinical trial update evaluating subclinical atherosclerosis using dual-source CT coronary angiography in Chinese adults with varying glycem…
-
CLINICAL_TRIALS trial_result · 2011-02-21Clinical Trial Update: Heparin or Enoxaparin in Patients With Cancer
A completed clinical trial evaluated the use of heparin versus enoxaparin in cancer patients to assess outcomes related to thrombosis and ca…
-
CLINICAL_TRIALS trial_result · 2010-09-16Clinical Trial Update: Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus [Phase 4]
Phase 4 trial update on using aspirin and statins to prevent atherosclerosis and arterial thromboembolism in systemic lupus erythematosus; t…